Navigation Links
Risk of Stroke, Heart Disease in Women Lowered by Mediterranean Diet
Date:2/17/2009

BOSTON, Feb. 17 /PRNewswire-USNewswire/ -- Women who adhere to a traditional Mediterranean diet -- high in monounsaturated fat, plant proteins, whole grains and fish -- are at a lower risk for stroke and coronary heart disease, according to a study published this week in Circulation: Journal of the American Heart Association.

The research, led by Simmons College Nutrition Professor Teresa Fung, found that women whose diets most closely resembled the Mediterranean diet had a 29% reduction in heart disease risk, and a 13% reduction in stroke risk when compared with those women whose diets least resembled it. Diseases of the heart (coronary heart disease) and stroke are two of the top three leading causes of death in the U.S. for women and men.

"These are dramatic results," said Fung. Previous studies have shown an association between the Mediterranean diet and reduced risk of cardiovascular death in men and women. This study is one of the first to look at non-fatal events. "Women whose diets look like the Mediterranean diet are not only less likely to die from heart disease and stroke, but also less likely to have those diseases," she said.

This is the first large-scale study to focus on the non-fatal incidence of heart disease and stroke in women, said Fung. "Women whose diets look like the Mediterranean diet are not only less likely to die from heart disease and stroke, but are less likely to have those diseases," she said.

Foods and beverages common in this diet include monounsaturated fats, vegetables, whole grains, fish, moderate alcohol, and limited red meat, refined grains, and sweets.

During the study's 20 years of follow-up, researchers found 2,391 incidents of coronary heart disease, 1,763 strokes and a combined total of 1,077 fatal heart attacks and strokes.

Fung
'/>"/>

SOURCE Simmons College
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
2. Pressure Cycling Technology (PCT) Results in a Higher Yield of Proteins and in the Extraction of Proteins Not Previously Identified in Cancer, Stroke, and IVF Studies
3. Many Heart Attack Patients Dont Get Best Emergency Treatment
4. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
5. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
6. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
7. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
8. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
9. Its Only Heartburn...or is it? Chronic Heartburn a Risk Factor for Precursor to Esophageal Cancer
10. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
11. Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...FORD, Mass., Nov. 25 Hol... ), a leading developer, manufacturer and supplier...nd surgical products dedicated to serving the heal... of the Radiological Society of North America (RSN...ugh December 3, 2009 to highlight our new SecurVie...
(Date:11/25/2009)...HILADELPHIA, Nov. 25 ERT...l J. McKelvey, the Company,s President and CEO, an...ident and CFO, are scheduled to present at the 21s...:30 PM EST on December 1, 2009 in New York City, N...resentation by visiting the Company,s corporate we...
(Date:11/25/2009)..., Pa., Nov. 25 BioTrends Research ...TM) : Stelara report, the first in a multi-ph...e launch of Centocor Ortho-Biotech,s Stelara, from...ailability. Each wave of the report provides quan... and qualitative information from a subset of 20. ...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call 12831 1Younger People Appear More at Risk From New Swine Flu 50334 1Younger People Appear More at Risk From New Swine Flu 50334 2Younger People Appear More at Risk From New Swine Flu 50334 3Younger People Appear More at Risk From New Swine Flu 50334 4TAHU Takes on New Leadership During Vital Time in Health Insurance Industry 50330 1TAHU Takes on New Leadership During Vital Time in Health Insurance Industry 50330 2
...l target in inflammatory indications...ril 15 Roche announced today that it,will acquire...using on,therapeutics targeting PI3-kinase (PI3-K)...role in disease progression and in resistance to,c...dies have demonstrated,the activity of PI3-K inhib...
...rhythms, TAMPA, Fla., April 15 Stinger Systems, ...ro-stun technology today,announced that an animal ...as presented at the 2008 Rocky Mountain Bioenginee...e full paper is available for purchase from the,co...://www.rmbs.org , ABOUT STINGER SYSTEMS, Stinger...
Other Medicine Technology:Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing 2Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing 3Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing 4
(Date:11/27/2009)... Uploadable USB pedometers may be new, but they,re...ion of advanced accelerometer functionality and au...n over the accuracy of self-reported data. It,s no... participation in a fitness program. ,, CoreHea...liers to integrate this technology. "Our health ch...
(Date:11/27/2009)...FirstCall/ -- The Gymboree Corporation (Nasdaq: G...present at the NASDAQ OMX 23rd Investor Program, w... England, on Wednesday, December 2, 2009, at 11:45...The Gymboree Corporation,s presentation over the I...on "Our Company" at the bottom of the page, go to ...
(Date:11/27/2009)...Newswire-FirstCall/ -- Shamir Optical Industry Ltd...r of innovative products and technology to the oph...d of directors had declared a dividend distributio...imately NIS 37.62 million based on the November 25...imately US$ 0.609 (approximately NIS 2.3 based on ...
(Date:11/27/2009)...economic burdens, study predicts , , FRI...ple with diabetes in the United States is expected...dicts. , That would bring the total by 2034 to ...m 23.7 million today. , , At the same time, the ... the study also warns, rising from an estimated $1...
(Date:11/27/2009)...ual coloring books designed for children ages 2 to... educate - inform parents and children alike on a ...s to ABC,S and a host of other topics. , ...7, 2009 -- Today’s children have enough gadg...r of the day, but one of the oldest and simplest a...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
.... (OTC Bulletin Board: NILT.OB), a biopharmaceutic...diovascular disease, is pleased to announce the,ap... President of,Regulatory Affairs., "We believe Ja...kground will be of great value to Nile as we devel...
...on pharmaceuticals in water, LISLE, Ill., May 8 ...verning drinking water are not strict,enough, acco...he Water,Quality Association. The release of these...te has begun public hearings,to look into the issu...
...ladelphians are expected to join the Lupus WHAT: ...h live entertainment, information and refr...eness about lupus. Live music, giveaways, snacks ...ne., WHY: Although first recognized by medical ...
...,(Nasdaq: DIET ), leveraging the power of the Int... solutions to everyone, today announced that it wi...h 31, 2008, after the U.S.,equity markets close on...ern Time.,Participants may access the call by dial...
...ansmission of patient data from ...PAWTUCKET, R.I., May 8 /PRNewswire/,--InterCompone...nology,solutions and Memorial Hospital of Rhode Is...r Primary Care and Prevention,which tests an eHeal...
... recognizes innovative product launch...8 Mangos, a full-service advertising,agency, took...Advertising,Award competition, sponsored by the He...d from a field of over 4400 entries, Mangos captur...
Other Medicine News:Health News:Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics 2Health News:Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics 3Health News:Half of Americans Want Stricter Water Quality Laws, Survey Finds 2Health News:5th Annual World Lupus Day Philadelphians Take Part In a Global Rally of Support 2Health News:eDiets.com(R) to Report First Quarter 2008 Results on Tuesday, May 13, 2008 2Health News:InterComponentWare Inc. and Memorial Hospital of Rhode Island Celebrate Milestone 2Health News:InterComponentWare Inc. and Memorial Hospital of Rhode Island Celebrate Milestone 3Health News:InterComponentWare Inc. and Memorial Hospital of Rhode Island Celebrate Milestone 4Health News:Mangos Captures 11 HMR Awards 2
Gibco Gentamicin Reagent Solution (50 mg/ml), liquid
LB Agar Plates Magnesium Sulfate-10
LB Agar
L-BROTH, liquid, 5 g NaCl
Medicine Products: